Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
3186studies shown
Showing 1,051-1,075 of 3,186
RecruitingNCT02361554

Deep Brain Stimulation in Treatment Resistant Schizophrenia

This study is looking at whether a digital support tool can help people with Treatment-resistant Schizophrenia. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 22 Years to 65 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
RecruitingNCT05527210

Prebiotic Treatment in People With Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia or schizoaffective disorder. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
RecruitingNCT07010614

Brain Stimulation to the Hippocampus in Schizophrenia

This study is looking at whether Intracranial electrodes can help people with Schizophrenia Disorders, Mental Disorder, or psychosis. Participants take part in Intracranial electrodes and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Stanford University
Condition
Schizophrenia
RecruitingNCT07434479

A Virtual Reality Mindfulness Application for Aggression in Schizophrenia

This study is looking at whether an online mindfulness program can help people with Schizophrenia Disorder, Schizoaffecitve Disorder, or Aggression. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 64 Years
Countries
United States
Sponsor
Manhattan Psychiatric Center
Condition
Schizophrenia
RecruitingNCT04368039

Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis

This study is looking at whether Normobaric Oxygen can help people with Psychosis, Schizophrenia, or First-episode Psychosis. Participants take part in Normobaric Oxygen and complete follow-up assessments.

SchizophreniaOtherFrom 15 Years to 35 Years
Countries
United States
Sponsor
Nicholas Breitborde
Condition
Schizophrenia
Enrolling By InvitationNCT03970005

Evaluation of Step-Based Care for Individuals at Clinical High Risk for Psychosis

This study is looking at evaluate the long-term outcomes among individuals participating in this clinical service for people with Prodromal Schizophrenia. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
Ohio State University
Condition
Schizophrenia
RecruitingNCT07196462

Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia

This study is comparing 3 Minute iTBS to the L DLPFC with Precision Brain Stimulation for Cannabis Users with Healthy Controls for people with Cannabis Use, Schizophrenia, Psychosis, or Rtms. Participants receive 3 Minute iTBS to the L DLPFC or Precision Brain Stimulation for Cannabis Users with Healthy Controls and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Schizophrenia
RecruitingNCT06865937

Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)

This study is looking at whether Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) can help people with Schizophenia Disorder or schizoaffective disorder. Participants take part in Mobile Intervention for Social Recovery in Serious Mental Illness (mSITE) and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia
RecruitingNCT07288567

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

This study is looking at evaluate the efficacy and safety of KarXT for treatment of Schizophrenia in adolescents. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 13 Years to 17 Years
Countries
Argentina, Colombia, Japan, Romania, United States
Sponsor
Bristol-Myers Squibb
Condition
Schizophrenia
RecruitingNCT06641297

White Matter Plasticity in Schizophrenia

This study is looking at care and outcomes for people with Schizophrenia Disorders. Taking part may give some people access to Music video game, but direct benefit is not guaranteed.

SchizophreniaOtherFrom 15 Years to 45 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Not Yet RecruitingNCT07423546

A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia

This study is looking at whether Xanomeline and trospium chloride (KarXT) can help people with SCHIZOPHRENIA 1 or Schizoaffecitve Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
RecruitingNCT07419321

Social Isolation and Aging in Schizophrenia

This study is looking at be the first to comprehensively examine the health impact of social isolation in SZ for people with Schizophrenia and Related Disorders. Participants are followed over time so researchers can learn from clinical and follow-up information.

SchizophreniaOtherFrom 40 Years to 70 Years
Countries
Netherlands, Spain, United Kingdom, United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Schizophrenia
Active Not RecruitingNCT04646200

CBT-I to Improve Functional Outcomes in Veterans With Psychosis

This study is looking at whether cognitive behavioural therapy can help people with Insomnia or Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 80 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Not Yet RecruitingNCT07417904

BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis

This study is looking at whether cognitive behavioural therapy can help people with Violence Risk or Early Psychosis. Participants take part in cognitive behavioural therapy and complete follow-up assessments.

SchizophreniaOtherFrom 18 Years to 30 Years
Countries
United States
Sponsor
Howard University
Condition
Schizophrenia
RecruitingNCT07231497

Cognitive Strategies in Early Psychosis 1

This study is looking at whether a digital support tool can help people with Cognition or Healthy Participants. Participants receive a study treatment and complete follow-up visits and assessments.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Not Yet RecruitingNCT07006935

REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)

This observational study is following people with Schizophrenia, Schizo Affective Disorder, or Schizophreniform Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
Case Western Reserve University
Condition
Schizophrenia
Active Not RecruitingNCT05558332

Youth Nominated Support Team

This study is looking at adapt the current Youth-Nominated Support Team (YST) manual used to treat suicide risk for people at clinical high risk for psychosis for people with Psychosis, Suicide, Health Care Utilization, or Family Members. Participants take part in a digital support tool and complete follow-up assessments.

SchizophreniaOtherFrom 12 Years to 25 Years
Countries
United States
Sponsor
University of California, Irvine
Condition
Schizophrenia
RecruitingNCT07217652

Investigating Mediodorsal Thalamus Representations Underlying Human Cognitive Flexibility

This study is looking at examine how the human thalamus supports flexible thinking and behavior for people with Schizophrenia or Attention Deficit Disorder With Hyperactivity. Some participants may receive Within subject manipulation of working memory, cognitive control, and decision making instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Kai Hwang
Condition
Schizophrenia
RecruitingNCT06155682

TMS for Inhibition Enhancement in Schizophrenia

This study is comparing repetitive transcranial magnetic stimulation (active) with sham rTMS for people with Schizophrenia. Participants receive repetitive transcranial magnetic stimulation (active) or sham rTMS and complete study visits and assessments.

SchizophreniaOtherFrom 18 Years to 45 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Active Not RecruitingNCT05857137

Psychosis TMS Study

This study is looking at care and outcomes for people with Psychosis. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

SchizophreniaOtherFrom 18 Years to 35 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Schizophrenia
United States | Clinical Trials | HopeStage Research